| Symbol | LMED |
|---|---|
| Name | LATAMED AI CORP. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 1071 Venezuela Av. Rómulo Gallegos con Av. Las Palmas Edif. Torre Gerencial Los Andes, Piso 4 |
| Telephone | +1 787 476 2350 |
| Fax | — |
| — | |
| Website | https://latamed.ai |
| Incorporation | US |
| Incorporated On | 2008 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Blue Chip Accounting, LLC;Beckles & Company; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001477960 |
| Description | LataMed AI Corp. ("LMED") is a development-stage digital health technology company focused on the design and intended commercialization of artificial intelligence-driven healthcare analytics solutions and technology-enabled medical service platforms. The Companys platform consists of an artificial intelligence-enabled healthcare analytics system and a healthcare services coordination platform designed to integrate data analytics, telehealth infrastructure, and hybrid home-based medical services. The Companys technology is intended to support clinical decision-making, patient monitoring, and care coordination through a unified digital framework. Its business strategy includes phased deployment, an initial market focus in Latin America, and expansion through strategic partnerships and regulatory approvals. Additional info from OTC: |
No news found.